Journal History
| 2011 | The inaugural issue was released. JPM was published as a quarterly journal. The first Special Issue “Recent Advances in Personalized Medicine” was announced. |
| 2013 | JPM was indexed in Scopus/SciVerse. |
| 2014 | JPM was indexed in PubMed and PubMed Central (PMC). |
| 2016 | JPM announced the first edition of the Travel Awards. |
| 2018 | JPM was indexed in Emerging Sources Citation Index (ESCI) - Web of Science (Clarivate Analytics). JPM received CiteScore of 2.62, ranked 54/189 (Q1) in 'Medicine (miscellaneous)'. |
| 2019 | JPM was indexed in Science Citation Index Expanded (SCIE) - Web of Science (Clarivate Analytics), ranked in Q1. |
| 2020 | JPM received its First Impact Factor (4.433), ranked 10/102(Q1) in the category "Health Care Sciences & Services", 24/165(Q1) in the category "Medicine, General & Internal". |
| 2021 | JPM adopted a monthly publication schedule. JPM received 2020 Impact Factor (4.945), ranked 15/108(Q1) in the category " Health Care Sciences & Services", 31/169(Q1) in the category "Medicine, General & Internal". |
| 2022 | JPM received 2021 Impact Factor (3.508), covered in the category " Health Care Sciences & Services" and "Medicine, General & Internal". JPM organized the first webinar "Radiation Response Biomarkers for Individualised Cancer Treatments". JPM established the following sections: -Personalized Therapy and Drug Delivery; -Evidence Based Medicine; -Regenerative Medicine and Therapeutics; -Epigenetic Therapy; -Sex, Gender and Hormone Based Medicine. |
| 2023 | JPM has established the following sections: -Disease Biomarker; -Life Stage Specific Medicine (LSSM); -Personalized Critical Care; -Molecular Targeted Therapy. |
Editor-in-Chief
| 2011–2015 | Editor-in-Chief: Prof. Dr. Urs A. Meyer |
| 2015–2021 | Editor-in-Chief: Prof. Dr. Stephen B. Liggett |
| 2021–present | Editor-in-Chief: Prof. Dr. David Alan Rizzieri |
Section Editor-in-Chief
| 2021–2023 | Section Editor-in-Chief: Prof. Dr. Richard E. Frye for the section on Mechanisms of Diseases |
| 2021–present | Section Editor-in-Chief: Prof. Dr. Enrico Mini for the section on Pharmacogenetics Section Editor-in-Chief: Prof. Dr. Kenneth P.H. Pritzker for the section on Clinical Medicine, Cell, and Organism Physiology Section Editor-in-Chief: Prof. Dr. K. Ray Chaudhuri for the section on Methodology, Drug and Device Discovery |
| 2022–present | Section Editor-in-Chief: Prof. Dr. Salvatore Scacco for the section on Omics/Informatics Section Editor-in-Chief: Prof. Dr. Marijn Speeckaert for the section on Epidemiology Section Editor-in-Chief: Prof. Dr. Liang Cheng for the section on Personalized Therapy and Drug Delivery Section Editor-in-Chief: Prof. Dr. Taulant Muka for the section on Evidence Based Medicine |
| 2023–present | Section Editor-in-Chief: Prof. Dr. Anat Biegon for the section on Sex, Gender and Hormone Based Medicine Section Editor-in-Chief: Prof. Dr. Lorenza Rimassa for the section on Disease Biomarker Section Editor-in-Chief: Prof. Dr. Weikuan Gu for the section on Life Stage Specific Medicine (LSSM) |
